In a 65-year-old female with major depressive disorder and generalized anxiety disorder who was weaned off vortioxetine (Trintellix) and is currently taking quetiapine (Seroquel) 200 mg at bedtime, what antidepressant would be appropriate?

Recommended Antidepressant Selection

Start sertraline 25-50 mg daily or escitalopram 10 mg daily as first-line treatment for this 65-year-old woman with MDD and GAD who failed vortioxetine. These SSRIs are well-tolerated in older adults, effective for both depression and anxiety, and have favorable safety profiles with her current quetiapine regimen 1, 2, 3.

Rationale for SSRI Selection

Sertraline is the preferred choice among SSRIs for older adults because:

• Well-tolerated with fewer drug-drug interactions compared to other SSRIs 1
• Effective for both MDD and comorbid GAD 3
• Lower anticholinergic burden than paroxetine 1
• Recommended maximum dose of 200 mg/day provides titration flexibility 1

Escitalopram is an excellent alternative with:

• Least effect on CYP450 enzymes, minimizing interactions with quetiapine 4
• Well-tolerated in elderly patients 1
• Important caveat: Maximum dose is 10 mg/day in patients >60 years due to QT prolongation risk 5

Critical Safety Considerations with Quetiapine

Since she's already taking quetiapine 200 mg nightly, be aware of:

• Serotonin syndrome risk: Monitor closely when combining quetiapine (which has serotonergic properties) with any SSRI, especially in the first 24-48 hours after starting or dose changes 4
• QT prolongation: Avoid citalopram (which has higher QT risk) given quetiapine's cardiac effects 4, 5, 6
• Additive sedation: Both quetiapine and SSRIs can cause somnolence 6

Practical Prescribing Approach

Start low and go slow in this 65-year-old patient:

1. Sertraline: Begin 25 mg daily for 1 week, then increase to 50 mg daily

   • Increase by 25-50 mg every 1-2 weeks as tolerated 1, 4
   • Target dose: 100-150 mg/day for MDD with GAD

2. Escitalopram: Begin 5 mg daily for 1 week, then increase to 10 mg daily

   • Do not exceed 10 mg/day in patients >60 years 5

Monitor closely:

• Assess within 1-2 weeks of initiation for suicidality, worsening depression, or agitation 2
• Evaluate response at 6-8 weeks; if inadequate, consider switching or augmentation 2, 7
• Watch for serotonin syndrome symptoms: confusion, agitation, tremors, hyperreflexia, tachycardia 4

Alternative Considerations

If SSRIs are not tolerated or contraindicated:

• Duloxetine 30 mg daily (SNRI): Effective for both MDD and GAD, start 30 mg once daily for 1 week before increasing to 60 mg 8, 3

  • Monitor blood pressure in elderly patients 8

• Mirtazapine 7.5 mg at bedtime: Particularly useful if insomnia is prominent, promotes sleep and appetite 1

  • May cause significant sedation and weight gain 1

Why Not Continue or Restart Vortioxetine?

While vortioxetine has demonstrated efficacy in MDD with anxiety 9, 10, 11, 12 and may have cognitive benefits in elderly patients 10, she already failed this medication, making it an inappropriate choice. The evidence supports switching to a different class rather than retrialing the same failed agent 2, 7.

Common Pitfalls to Avoid

• Don't use paroxetine: Higher anticholinergic effects, more drug interactions, worse discontinuation syndrome, and increased suicidal thinking risk compared to other SSRIs 4
• Avoid benzodiazepines for acute anxiety: Despite her fear of being home alone, benzodiazepines carry fall risk, cognitive impairment, and dependence concerns in elderly patients 3
• Don't underdose: Ensure adequate trial duration (6-8 weeks at therapeutic dose) before declaring treatment failure 2
• Don't forget psychotherapy: Consider adding cognitive behavioral therapy, which has demonstrated efficacy for both MDD and GAD 4

Expected Timeline

• Early response: Some anxiety reduction may occur within 1-2 weeks 4, 13
• Full assessment: Evaluate treatment response at 6-8 weeks 2
• Continuation: If effective, continue for 4-9 months minimum; longer duration for recurrent depression 2